|
Media Releases |
Financial Reports |
Presen-tations |
|
09/13/2005
|
|
|
|
| Lonza expands its production capacities for the manufacture of Active Phar-maceutical Ingredients (API) in Visp |
Lonza announces the expansion of its cGMP production capacity in the multipurpose plants at the Visp site in Switzerland. The expansion will take place in several stages. In the first stage a new building will be erected and the drying capacity enlarged. The completion of the building is scheduled for the end of the first quarter in 2006, and the start-up of the drying installation at the end of 2006. The investment for the first phase together with the partial expansion will amount to CHF 23 million.
Further expansion stages will be closely linked to customer requirements: two production trains for final products are planned and up to three drying trains with milling and micronizing are to be realized.
The increase in capacity is a result of the growing demand for active pharmaceutical ingredients (APIs) which are exclusively produced for our world wide customers. Thus the ever-increasing hygienic and regulatory requirements can be met in custom synthesis of APIs.
Lonza, a chemical and biotechnology company driven by the life sciences, gener-ated sales of CHF 2.18 billion in 2004. Headquartered in Switzerland, Lonza operates 18 production and R&D sites around the world. Its 5700 employees are passionately committed to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic chemical, oleochemical and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Further information can be found on our website www.lonza.com.
For further information:
Lonza Group AG
Media Relations
Christine Menz
Tel +41 61 316 8253
Fax +41 61 316 9253
christine.menz@lonza.com
Lonza Group AG
Investor Relations
Laura Gerber
Tel +41 61 316 8347
Fax +41 61 316 8220
laura.gerber@lonza.com
|
|
|
